Drybench Patent.
Patent and exclusivity dates from July to December 2032 for NDAs, as FDA's Orange Book lists them
Each patent and exclusivity date from July to December 2032 that FDA's Orange Book lists for an NDA, as captured on 14 October 2026. That capture lists a patent or exclusivity for 1,411 NDAs. Each entry is named by its rule and linked to its NDA page. A date here belongs to one patent or one exclusivity on the products named; the same NDA may have other listed dates, earlier or later, so no date here stands for a product.
FDA capture · review pending. Each date is shown as captured from FDA's Orange Book files. Dates are as FDA lists them, and Drybench computes none; patent dates are submitted by the applicant, and FDA does not verify them. Spreadsheet day numbers are shown as dates; a cell that cannot be read as one date is left off this page and shown as written on its NDA page. Where FDA lists a *PED row without flags, its flags are read from the base row and marked so. How this page reads FDA's files has not been independently reviewed by a regulatory-affairs reviewer.
- Orange Book captured
- 14 October 2026
Listed protection is a range of the dates FDA lists, not a forecast of market entry, and not legal, regulatory or investment advice.
This page covers every NDA whose Orange Book capture lists a patent or exclusivity. It does not cover ANDAs or any BLA. NCE exclusivity dates are here as FDA lists them; NCE-1 dates, computed from them, are on the NCE-1 calendar.
Dates as listed in FDA's Orange Book capture of 14 October 2026. This page does not say whether a date has passed; compare it with today's date and FDA's current Orange Book. This page shows only what the capture of 14 October 2026 lists. It does not show patents or exclusivities listed before and since removed.
NCE-1, one year before a listed NCE exclusivity date and the one date Drybench computes, is on its own page: NCE-1 dates from the Orange Book
Listed dates, 2032January to June 2032
Listed patent expiry (305)
3 Jul 2032 · NDA 217424 · BERDAZIMER SODIUM
US 10,265,334, product patent
patent.txt line 19,926- Flags
- product
- Product numbers
- 001
3 Jul 2032 · NDA 217424 · BERDAZIMER SODIUM
US 9,289,442, product and use patent
patent.txt line 19,940- Flags
- product use code U-3803
- Product numbers
- 001
9 Jul 2032 · NDA 203085 · REGORAFENIB
US 9,957,232, substance patent
patent.txt line 3,608- Flags
- substance
- Product numbers
- 001
9 Jul 2032 · NDA 208694 · CETIRIZINE HYDROCHLORIDE
US 9,254,286, product patent
patent.txt line 9,240- Flags
- product
- Product numbers
- 001
11 Jul 2032 · NDA 210259 · ACALABRUTINIB
US 10,239,883, use patent
patent.txt line 11,246- Flags
- use code U-2666
- Product numbers
- 001
11 Jul 2032 · NDA 210259 · ACALABRUTINIB
US 10,239,883, use patent
patent.txt line 11,247- Flags
- use code U-2668
- Product numbers
- 001
11 Jul 2032 · NDA 210259 · ACALABRUTINIB
US 9,290,504, substance and product patent
patent.txt line 11,264- Flags
- substance product
- Product numbers
- 001
11 Jul 2032 · NDA 210259 · ACALABRUTINIB
US 9,758,524, use patent
patent.txt line 11,265- Flags
- use code U-2145
- Product numbers
- 001
11 Jul 2032 · NDA 210259 · ACALABRUTINIB
US 9,758,524, use patent
patent.txt line 11,266- Flags
- use code U-4108
- Product numbers
- 001
11 Jul 2032 · NDA 216387 · ACALABRUTINIB MALEATE
US 10,239,883, use patent
patent.txt line 18,765- Flags
- use code U-2666
- Product numbers
- 001
11 Jul 2032 · NDA 216387 · ACALABRUTINIB MALEATE
US 10,239,883, use patent
patent.txt line 18,766- Flags
- use code U-2668
- Product numbers
- 001
11 Jul 2032 · NDA 216387 · ACALABRUTINIB MALEATE
US 9,290,504, substance and product patent
patent.txt line 18,791- Flags
- substance product
- Product numbers
- 001
11 Jul 2032 · NDA 216387 · ACALABRUTINIB MALEATE
US 9,758,524, use patent
patent.txt line 18,792- Flags
- use code U-2145
- Product numbers
- 001
11 Jul 2032 · NDA 216387 · ACALABRUTINIB MALEATE
US 9,758,524, use patent
patent.txt line 18,793- Flags
- use code U-4108
- Product numbers
- 001
14 Jul 2032 · NDA 204677 · FLORBETABEN F-18
US 9,308,284, product patent
patent.txt line 4,980- Flags
- product
- Product numbers
- 001
14 Jul 2032 · NDA 208399 · ROLAPITANT HYDROCHLORIDE
US 9,101,615, use patent
patent.txt line 8,571- Flags
- use code U-1741
- Product numbers
- 001
18 Jul 2032 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 8,569,328, product and use patent
patent.txt line 17,080- Flags
- product use code U-3419
- Product numbers
- 001
18 Jul 2032 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 8,569,328, product and use patent
patent.txt lines 17,081, 17,158- Flags
- product use code U-4516
- Product numbers
- 001, 002
19 Jul 2032 · NDA 211765 · UBROGEPANT
US 8,754,096, substance and product and use patent
patent.txt lines 13,167, 13,179- Flags
- substance product use code U-2717
- Product numbers
- 001, 002
25 Jul 2032 · NDA 208065 · OSIMERTINIB MESYLATE
US 11,524,951, substance and product patent
patent.txt lines 8,054, 8,071- Flags
- substance product
- Product numbers
- 001, 002
25 Jul 2032 · NDA 208065 · OSIMERTINIB MESYLATE
US 9,732,058, substance and product and use patent
patent.txt lines 8,061, 8,078- Flags
- substance product use code U-1777
- Product numbers
- 001, 002
25 Jul 2032 · NDA 208065 · OSIMERTINIB MESYLATE
US 9,732,058, substance and product and use patent
patent.txt lines 8,062, 8,079- Flags
- substance product use code U-2289
- Product numbers
- 001, 002
25 Jul 2032 · NDA 208065 · OSIMERTINIB MESYLATE
US 9,732,058, substance and product and use patent
patent.txt lines 8,063, 8,080- Flags
- substance product use code U-3016
- Product numbers
- 001, 002
25 Jul 2032 · NDA 208065 · OSIMERTINIB MESYLATE
US 9,732,058, substance and product and use patent
patent.txt lines 8,064, 8,081- Flags
- substance product use code U-3823
- Product numbers
- 001, 002
25 Jul 2032 · NDA 208065 · OSIMERTINIB MESYLATE
US 9,732,058, substance and product and use patent
patent.txt lines 8,065, 8,082- Flags
- substance product use code U-4010
- Product numbers
- 001, 002
26 Jul 2032 · NDA 210136 · BUPRENORPHINE
US 10,912,772, use patent
patent.txt lines 11,148, 11,156, 11,164, 11,172, 11,180, 11,188, 11,196- Flags
- use code U-3617
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
26 Jul 2032 · NDA 210136 · BUPRENORPHINE
US 11,110,084, product and use patent
patent.txt lines 11,149, 11,157, 11,165, 11,173, 11,181, 11,189, 11,197- Flags
- product use code U-3616
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
26 Jul 2032 · NDA 210136 · BUPRENORPHINE
US 11,135,215, product patent
patent.txt lines 11,150, 11,158, 11,166, 11,174, 11,182, 11,190, 11,198- Flags
- product
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
26 Jul 2032 · NDA 210136 · BUPRENORPHINE
US 12,161,640, product and use patent
patent.txt lines 11,151, 11,159, 11,167, 11,175, 11,183, 11,191, 11,199- Flags
- product use code U-4100
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
26 Jul 2032 · NDA 210136 · BUPRENORPHINE
US 12,318,379, product and use patent
patent.txt lines 11,152, 11,160, 11,168, 11,176, 11,184, 11,192, 11,200- Flags
- product use code U-4100
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
26 Jul 2032 · NDA 210136 · BUPRENORPHINE
US 9,937,164, product and use patent
patent.txt lines 11,155, 11,163, 11,171, 11,179, 11,187, 11,195, 11,203- Flags
- product use code U-3618
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
26 Jul 2032 · NDA 212306 · SELINEXOR
US 10,544,108, use patent
patent.txt lines 13,833, 13,853, 13,872, 13,891, 13,910, 13,929- Flags
- use code U-2584
- Product numbers
- 001, 002, 003, 004, 005, 006
26 Jul 2032 · NDA 212306 · SELINEXOR
US 10,544,108, use patent
patent.txt lines 13,834, 13,854, 13,873, 13,892, 13,911, 13,930- Flags
- use code U-3018
- Product numbers
- 001, 002, 003, 004, 005, 006
26 Jul 2032 · NDA 212306 · SELINEXOR
US 11,034,660, use patent
patent.txt lines 13,835, 13,855, 13,874, 13,893, 13,912, 13,931- Flags
- use code U-2584
- Product numbers
- 001, 002, 003, 004, 005, 006
26 Jul 2032 · NDA 212306 · SELINEXOR
US 11,034,660, use patent
patent.txt lines 13,836, 13,856, 13,875, 13,894, 13,913, 13,932- Flags
- use code U-3018
- Product numbers
- 001, 002, 003, 004, 005, 006
26 Jul 2032 · NDA 212306 · SELINEXOR
US 11,787,771, use patent
patent.txt line 13,842- Flags
- use code U-2855
- Product numbers
- 001
26 Jul 2032 · NDA 212306 · SELINEXOR
US 11,787,771, use patent
patent.txt lines 13,841, 13,861, 13,880, 13,899, 13,918, 13,937- Flags
- use code U-2584
- Product numbers
- 001, 002, 003, 004, 005, 006
26 Jul 2032 · NDA 212306 · SELINEXOR
US 11,787,771, use patent
patent.txt lines 13,843, 13,862, 13,881, 13,900, 13,919, 13,938- Flags
- use code U-3018
- Product numbers
- 001, 002, 003, 004, 005, 006
26 Jul 2032 · NDA 212306 · SELINEXOR
US 12,291,508, use patent
patent.txt lines 13,845, 13,864, 13,883, 13,902, 13,921, 13,940- Flags
- use code U-2584
- Product numbers
- 001, 002, 003, 004, 005, 006
26 Jul 2032 · NDA 212306 · SELINEXOR
US 12,291,508, use patent
patent.txt lines 13,846, 13,865, 13,884, 13,903, 13,922, 13,941- Flags
- use code U-3018
- Product numbers
- 001, 002, 003, 004, 005, 006
26 Jul 2032 · NDA 212306 · SELINEXOR
US 9,079,865, use patent
patent.txt lines 13,848, 13,867, 13,886, 13,905, 13,924, 13,943- Flags
- use code U-2584
- Product numbers
- 001, 002, 003, 004, 005, 006
26 Jul 2032 · NDA 212306 · SELINEXOR
US 9,079,865, use patent
patent.txt lines 13,849, 13,868, 13,887, 13,906, 13,925, 13,944- Flags
- use code U-3018
- Product numbers
- 001, 002, 003, 004, 005, 006
26 Jul 2032 · NDA 212306 · SELINEXOR
US 9,714,226, substance and product patent
patent.txt lines 13,850, 13,869, 13,888, 13,907, 13,926, 13,945- Flags
- substance product
- Product numbers
- 001, 002, 003, 004, 005, 006
27 Jul 2032 · NDA 209299 · FOSTAMATINIB DISODIUM
US 8,771,648, product patent
patent.txt lines 10,046, 10,060- Flags
- product
- Product numbers
- 001, 002
27 Jul 2032 · NDA 209299 · FOSTAMATINIB DISODIUM
US 8,951,504, use patent
patent.txt lines 10,048, 10,062- Flags
- use code U-2294
- Product numbers
- 001, 002
7 Aug 2032 · NDA 022196 · ZOLPIDEM TARTRATE
US 8,236,285, substance and product and use patent
patent.txt line 1,241- Flags
- substance product use code U-70
- Product numbers
- 001
8 Aug 2032 · NDA 208065 · OSIMERTINIB MESYLATE
US 8,946,235, substance and product and use patent
patent.txt lines 8,056, 8,073- Flags
- substance product use code U-1777
- Product numbers
- 001, 002
8 Aug 2032 · NDA 208065 · OSIMERTINIB MESYLATE
US 8,946,235, substance and product and use patent
patent.txt lines 8,057, 8,074- Flags
- substance product use code U-2289
- Product numbers
- 001, 002
8 Aug 2032 · NDA 208065 · OSIMERTINIB MESYLATE
US 8,946,235, substance and product and use patent
patent.txt lines 8,058, 8,075- Flags
- substance product use code U-3016
- Product numbers
- 001, 002
8 Aug 2032 · NDA 208065 · OSIMERTINIB MESYLATE
US 8,946,235, substance and product and use patent
patent.txt lines 8,059, 8,076- Flags
- substance product use code U-3823
- Product numbers
- 001, 002
8 Aug 2032 · NDA 208065 · OSIMERTINIB MESYLATE
US 8,946,235, substance and product and use patent
patent.txt lines 8,060, 8,077- Flags
- substance product use code U-4010
- Product numbers
- 001, 002
8 Aug 2032 · NDA 208627 · TECOVIRIMAT
US 11,890,270, use patent
patent.txt line 9,012- Flags
- use code U-2346
- Product numbers
- 001
10 Aug 2032 · NDA 208547 · GALLIUM DOTATATE GA-68
US 9,375,498, product patent
patent.txt line 8,670- Flags
- product
- Product numbers
- 001
10 Aug 2032 · NDA 210922 · PATISIRAN SODIUM
US 8,168,775, substance and product and use patent
patent.txt line 12,399- Flags
- substance product use code U-2378
- Product numbers
- 001
11 Aug 2032 · NDA 209381 · ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
US 9,592,252, product and use patent
patent.txt line 10,285- Flags
- product use code U-2310
- Product numbers
- 001
14 Aug 2032 · NDA 218201 · COPPER
US 10,159,596, product patent
patent.txt line 20,893- Flags
- product
- Product numbers
- 001
14 Aug 2032 · NDA 218201 · COPPER
US 10,188,546, product patent
patent.txt line 20,895- Flags
- product
- Product numbers
- 001
14 Aug 2032 · NDA 218201 · COPPER
US 11,850,181, product patent
patent.txt line 20,899- Flags
- product
- Product numbers
- 001
14 Aug 2032 · NDA 218201 · COPPER
US 9,427,351, product patent
patent.txt line 20,904- Flags
- product
- Product numbers
- 001
15 Aug 2032 · NDA 207561 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065, substance and product and use patent
patent.txt line 7,357- Flags
- substance product use code U-257
- Product numbers
- 001
15 Aug 2032 · NDA 207561 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769, substance and product and use patent
patent.txt line 7,361- Flags
- substance product use code U-257
- Product numbers
- 001
15 Aug 2032 · NDA 208215 · EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065, substance and product and use patent
patent.txt line 8,336- Flags
- substance product use code U-1259
- Product numbers
- 001
15 Aug 2032 · NDA 208215 · EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065, substance and product and use patent
patent.txt line 8,338- Flags
- substance product use code U-257
- Product numbers
- 001
15 Aug 2032 · NDA 208215 · EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065, substance and product and use patent
patent.txt lines 8,337, 8,345- Flags
- substance product use code U-1663
- Product numbers
- 001, 002
15 Aug 2032 · NDA 208215 · EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769, substance and product and use patent
patent.txt line 8,340- Flags
- substance product use code U-1259
- Product numbers
- 001
15 Aug 2032 · NDA 208215 · EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769, substance and product and use patent
patent.txt line 8,342- Flags
- substance product use code U-257
- Product numbers
- 001
15 Aug 2032 · NDA 208215 · EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769, substance and product and use patent
patent.txt lines 8,341, 8,347- Flags
- substance product use code U-1663
- Product numbers
- 001, 002
15 Aug 2032 · NDA 208351 · EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065, substance and product and use patent
patent.txt line 8,544- Flags
- substance product use code U-257
- Product numbers
- 001
15 Aug 2032 · NDA 208351 · EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769, substance and product and use patent
patent.txt line 8,546- Flags
- substance product use code U-257
- Product numbers
- 001
15 Aug 2032 · NDA 208464 · TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065, substance and product and use patent
patent.txt line 8,660- Flags
- substance product use code U-1275
- Product numbers
- 001
15 Aug 2032 · NDA 208464 · TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065, substance and product and use patent
patent.txt line 8,661- Flags
- substance product use code U-3880
- Product numbers
- 001
15 Aug 2032 · NDA 208464 · TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065, substance and product and use patent
patent.txt line 8,662- Flags
- substance product use code U-999
- Product numbers
- 001
15 Aug 2032 · NDA 208464 · TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769, substance and product and use patent
patent.txt line 8,664- Flags
- substance product use code U-1275
- Product numbers
- 001
15 Aug 2032 · NDA 208464 · TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769, substance and product and use patent
patent.txt line 8,665- Flags
- substance product use code U-3880
- Product numbers
- 001
15 Aug 2032 · NDA 208464 · TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769, substance and product and use patent
patent.txt line 8,666- Flags
- substance product use code U-999
- Product numbers
- 001
15 Aug 2032 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065, substance and product and use patent
patent.txt lines 11,216, 11,225- Flags
- substance product use code U-257
- Product numbers
- 001, 002
15 Aug 2032 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769, substance and product and use patent
patent.txt lines 11,219, 11,228- Flags
- substance product use code U-257
- Product numbers
- 001, 002
15 Aug 2032 · NDA 210455 · COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065, substance and product and use patent
patent.txt line 11,410- Flags
- substance product use code U-2352
- Product numbers
- 001
15 Aug 2032 · NDA 210455 · COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,754,065, substance and product and use patent
patent.txt line 11,411- Flags
- substance product use code U-2765
- Product numbers
- 001
15 Aug 2032 · NDA 210455 · COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769, substance and product and use patent
patent.txt line 11,412- Flags
- substance product use code U-2352
- Product numbers
- 001
15 Aug 2032 · NDA 210455 · COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,296,769, substance and product and use patent
patent.txt line 11,413- Flags
- substance product use code U-2765
- Product numbers
- 001
20 Aug 2032 · NDA 205637 · BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US 8,703,177, product patent
patent.txt lines 5,699, 5,703, 5,707- Flags
- product
- Product numbers
- 001, 002, 003
20 Aug 2032 · NDA 208745 · PLECANATIDE
US 9,616,097, product patent
patent.txt line 9,311- Flags
- product
- Product numbers
- 001
21 Aug 2032 · NDA 213793 · SETMELANOTIDE ACETATE
US 8,039,435, substance and product patent
patent.txt line 15,271- Flags
- substance product
- Product numbers
- 001
23 Aug 2032 · NDA 213227 · COPPER CU-64 DOTATATE
US 10,159,759, use patent
patent.txt line 14,810- Flags
- use code U-2951
- Product numbers
- 001
23 Aug 2032 · NDA 213227 · COPPER CU-64 DOTATATE
US 11,160,888, use patent
patent.txt line 14,812- Flags
- use code U-2951
- Product numbers
- 001
23 Aug 2032 · NDA 218764 · NERANDOMILAST
US 8,609,670, substance patent
patent.txt lines 21,282, 21,289- Flags
- substance
- Product numbers
- 001, 002
24 Aug 2032 · NDA 022416 · ESLICARBAZEPINE ACETATE
US 9,750,747, use patent
patent.txt lines 1,820, 1,828, 1,836, 1,844- Flags
- use code U-2041
- Product numbers
- 001, 002, 003, 004
24 Aug 2032 · NDA 022416 · ESLICARBAZEPINE ACETATE
US 9,750,747, use patent
patent.txt lines 1,821, 1,829, 1,837, 1,845- Flags
- use code U-2121
- Product numbers
- 001, 002, 003, 004
24 Aug 2032 · NDA 220787 · CEFEPIME HYDROCHLORIDE; ZIDEBACTAM
US 8,822,450, substance and product patent
patent.txt line 22,387- Flags
- substance product
- Product numbers
- 001
24 Aug 2032 · NDA 220787 · CEFEPIME HYDROCHLORIDE; ZIDEBACTAM
US 8,853,197, substance patent
patent.txt line 22,388- Flags
- substance
- Product numbers
- 001
24 Aug 2032 · NDA 220787 · CEFEPIME HYDROCHLORIDE; ZIDEBACTAM
US 9,132,133, use patent
patent.txt line 22,389- Flags
- use code U-4558
- Product numbers
- 001
24 Aug 2032 · NDA 220787 · CEFEPIME HYDROCHLORIDE; ZIDEBACTAM
US 9,381,200, product patent
patent.txt line 22,390- Flags
- product
- Product numbers
- 001
24 Aug 2032 · NDA 220787 · CEFEPIME HYDROCHLORIDE; ZIDEBACTAM
US 9,827,235, product and use patent
patent.txt line 22,392- Flags
- product use code U-4558
- Product numbers
- 001
27 Aug 2032 · NDA 211109 · ERAVACYCLINE DIHYDROCHLORIDE
US 8,906,887, product patent
patent.txt lines 12,475, 12,479- Flags
- product
- Product numbers
- 001, 002
29 Aug 2032 · NDA 202231 · LEVOTHYROXINE SODIUM
US 9,168,238, product patent
patent.txt lines 2,948, 2,951, 2,954- Flags
- product
- Product numbers
- 001, 002, 003
29 Aug 2032 · NDA 202231 · LEVOTHYROXINE SODIUM
US 9,168,239, product patent
patent.txt lines 2,949, 2,952, 2,955- Flags
- product
- Product numbers
- 001, 002, 003
30 Aug 2032 · NDA 210806 · DORAVIRINE
US 8,486,975, substance and product and use patent
patent.txt line 12,152- Flags
- substance product use code U-2394
- Product numbers
- 001
30 Aug 2032 · NDA 210806 · DORAVIRINE
US 8,486,975, substance and product and use patent
patent.txt line 12,153- Flags
- substance product use code U-2630
- Product numbers
- 001
30 Aug 2032 · NDA 210806 · DORAVIRINE
US 8,486,975, substance and product and use patent
patent.txt line 12,154- Flags
- substance product use code U-3308
- Product numbers
- 001
30 Aug 2032 · NDA 210807 · DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
US 8,486,975, substance and product and use patent
patent.txt line 12,157- Flags
- substance product use code U-2395
- Product numbers
- 001
30 Aug 2032 · NDA 210807 · DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
US 8,486,975, substance and product and use patent
patent.txt line 12,158- Flags
- substance product use code U-2629
- Product numbers
- 001
30 Aug 2032 · NDA 210807 · DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
US 8,486,975, substance and product and use patent
patent.txt line 12,159- Flags
- substance product use code U-3307
- Product numbers
- 001
30 Aug 2032 · NDA 216964 · DORAVIRINE; ISLATRAVIR
US 8,486,975, substance and product and use patent
patent.txt line 19,088- Flags
- substance product use code U-4527
- Product numbers
- 001
30 Aug 2032 · NDA 219876 · DORDAVIPRONE HYDROCHLORIDE
US RE46290, use patent
patent.txt line 22,034- Flags
- use code U-4254
- Product numbers
- 001
1 Sep 2032 · NDA 208437 · GLYCOPYRROLATE
US 9,168,556, product patent
patent.txt line 8,626- Flags
- product
- Product numbers
- 001
4 Sep 2032 · NDA 206619 · DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US 8,466,159, use patent
patent.txt line 6,603- Flags
- use code U-1637
- Product numbers
- 001
4 Sep 2032 · NDA 206619 · DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US 8,492,386, use patent
patent.txt line 6,604- Flags
- use code U-1840
- Product numbers
- 001
4 Sep 2032 · NDA 206619 · DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US 8,680,106, use patent
patent.txt line 6,607- Flags
- use code U-1637
- Product numbers
- 001
4 Sep 2032 · NDA 206619 · DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US 8,685,984, use patent
patent.txt line 6,608- Flags
- use code U-1840
- Product numbers
- 001
4 Sep 2032 · NDA 208624 · DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR
US 8,466,159, use patent
patent.txt line 8,999- Flags
- use code U-1637
- Product numbers
- 001
4 Sep 2032 · NDA 208624 · DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR
US 8,492,386, use patent
patent.txt line 9,000- Flags
- use code U-1840
- Product numbers
- 001
4 Sep 2032 · NDA 208624 · DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR
US 8,680,106, use patent
patent.txt line 9,003- Flags
- use code U-1637
- Product numbers
- 001
4 Sep 2032 · NDA 208624 · DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR
US 8,685,984, use patent
patent.txt line 9,004- Flags
- use code U-1840
- Product numbers
- 001
5 Sep 2032 · NDA 213436 · DIHYDROERGOTAMINE MESYLATE
US 9,550,036, product patent
patent.txt line 15,017- Flags
- product
- Product numbers
- 001
7 Sep 2032 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,028,963, use patent
patent.txt line 6,769- Flags
- use code U-2565
- Product numbers
- 001
7 Sep 2032 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,028,963, use patent
patent.txt line 6,770- Flags
- use code U-2566
- Product numbers
- 001
7 Sep 2032 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,028,963, use patent
patent.txt line 6,771- Flags
- use code U-4542
- Product numbers
- 001
7 Sep 2032 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,028,963, use patent
patent.txt line 6,772- Flags
- use code U-4543
- Product numbers
- 001
7 Sep 2032 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 9,724,353, use patent
patent.txt line 6,818- Flags
- use code U-2565
- Product numbers
- 001
7 Sep 2032 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 9,724,353, use patent
patent.txt line 6,819- Flags
- use code U-2566
- Product numbers
- 001
7 Sep 2032 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 9,724,353, use patent
patent.txt line 6,820- Flags
- use code U-4542
- Product numbers
- 001
7 Sep 2032 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 9,724,353, use patent
patent.txt line 6,821- Flags
- use code U-4543
- Product numbers
- 001
14 Sep 2032 · NDA 205834 · LEDIPASVIR; SOFOSBUVIR
US 10,456,414, product patent
patent.txt lines 5,911, 5,944- Flags
- product
- Product numbers
- 001, 002
14 Sep 2032 · NDA 205834 · LEDIPASVIR; SOFOSBUVIR
US 9,393,256, use patent
patent.txt lines 5,939, 5,972- Flags
- use code U-1470
- Product numbers
- 001, 002
14 Sep 2032 · NDA 212477 · LEDIPASVIR; SOFOSBUVIR
US 10,456,414, product patent
patent.txt lines 13,984, 14,015- Flags
- product
- Product numbers
- 001, 002
14 Sep 2032 · NDA 212477 · LEDIPASVIR; SOFOSBUVIR
US 9,393,256, use patent
patent.txt lines 14,012, 14,043- Flags
- use code U-1470
- Product numbers
- 001, 002
18 Sep 2032 · NDA 204242 · BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US 10,874,661, product patent
patent.txt line 4,380- Flags
- product
- Product numbers
- 002
18 Sep 2032 · NDA 204242 · BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US 10,946,010, product patent
patent.txt lines 4,372, 4,381, 4,390, 4,399, 4,408, 4,417- Flags
- product
- Product numbers
- 001, 002, 003, 004, 005, 006
18 Sep 2032 · NDA 204242 · BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US 11,020,387, product and use patent
patent.txt lines 4,382, 4,391, 4,400, 4,409- Flags
- product use code U-3131
- Product numbers
- 002, 003, 004, 005
18 Sep 2032 · NDA 204242 · BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US 11,020,388, product and use patent
patent.txt lines 4,373, 4,383, 4,392, 4,401, 4,410, 4,418- Flags
- product use code U-3131
- Product numbers
- 001, 002, 003, 004, 005, 006
18 Sep 2032 · NDA 204242 · BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US 11,433,066, use patent
patent.txt lines 4,374, 4,384, 4,393, 4,402, 4,411- Flags
- use code U-3131
- Product numbers
- 001, 002, 003, 004, 005
18 Sep 2032 · NDA 204242 · BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US 8,940,330, product patent
patent.txt lines 4,377, 4,387, 4,396, 4,405, 4,414, 4,421- Flags
- product
- Product numbers
- 001, 002, 003, 004, 005, 006
18 Sep 2032 · NDA 204242 · BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US 9,259,421, product patent
patent.txt lines 4,378, 4,388, 4,397, 4,406, 4,415, 4,422- Flags
- product
- Product numbers
- 001, 002, 003, 004, 005, 006
18 Sep 2032 · NDA 204242 · BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US 9,439,900, product patent
patent.txt lines 4,379, 4,389, 4,398, 4,407, 4,416- Flags
- product
- Product numbers
- 001, 002, 003, 004, 005
24 Sep 2032 · NDA 211155 · DUVELISIB
US 8,193,182, substance patent
patent.txt lines 12,492, 12,500- Flags
- substance
- Product numbers
- 001, 002
27 Sep 2032 · NDA 211288 · DACOMITINIB
US 7,772,243, substance and product patent
patent.txt lines 12,677, 12,680, 12,683- Flags
- substance product
- Product numbers
- 001, 002, 003
29 Sep 2032 · NDA 203697 · ASPIRIN
US 10,646,431, product patent
patent.txt lines 4,117, 4,123- Flags
- product
- Product numbers
- 001, 002
29 Sep 2032 · NDA 203697 · ASPIRIN
US 10,786,444, use patent
patent.txt lines 4,118, 4,124- Flags
- use code U-3559
- Product numbers
- 001, 002
29 Sep 2032 · NDA 203697 · ASPIRIN
US 9,216,150, product patent
patent.txt line 4,119- Flags
- product
- Product numbers
- 001
29 Sep 2032 · NDA 203697 · ASPIRIN
US 9,226,892, use patent
patent.txt line 4,120- Flags
- use code U-1731
- Product numbers
- 001
29 Sep 2032 · NDA 203697 · ASPIRIN
US 9,226,892, use patent
patent.txt line 4,121- Flags
- use code U-1732
- Product numbers
- 001
29 Sep 2032 · NDA 203697 · ASPIRIN
US 9,226,892, use patent
patent.txt line 4,122- Flags
- use code U-1733
- Product numbers
- 001
3 Oct 2032 · NDA 202231 · LEVOTHYROXINE SODIUM
US 9,006,289, product patent
patent.txt lines 2,947, 2,950, 2,953- Flags
- product
- Product numbers
- 001, 002, 003
6 Oct 2032 · NDA 203094 · COBICISTAT
US 10,039,718, product patent
patent.txt lines 3,622, 3,626- Flags
- product
- Product numbers
- 001, 002
6 Oct 2032 · NDA 203100 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US 10,039,718, product patent
patent.txt line 3,630- Flags
- product
- Product numbers
- 001
6 Oct 2032 · NDA 205395 · COBICISTAT; DARUNAVIR ETHANOLATE
US 10,039,718, product patent
patent.txt lines 5,295, 5,301- Flags
- product
- Product numbers
- 001, 002
6 Oct 2032 · NDA 206353 · ATAZANAVIR SULFATE; COBICISTAT
US 10,039,718, product patent
patent.txt line 6,494- Flags
- product
- Product numbers
- 001
6 Oct 2032 · NDA 207561 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 10,039,718, product patent
patent.txt line 7,347- Flags
- product
- Product numbers
- 001
6 Oct 2032 · NDA 210455 · COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 10,039,718, product patent
patent.txt line 11,401- Flags
- product
- Product numbers
- 001
8 Oct 2032 · NDA 202278 · SUMATRIPTAN SUCCINATE
US 9,327,114, product and use patent
patent.txt line 2,973- Flags
- product use code U-1328
- Product numbers
- 001
12 Oct 2032 · NDA 205422 · BREXPIPRAZOLE
US 10,307,419, product patent
patent.txt lines 5,308, 5,321, 5,334, 5,347, 5,360- Flags
- product
- Product numbers
- 001, 002, 003, 004, 005
12 Oct 2032 · NDA 213411 · TUCATINIB
US 9,457,093, product and use patent
patent.txt lines 14,987, 14,994- Flags
- product use code U-2788
- Product numbers
- 001, 002
15 Oct 2032 · NDA 209401 · CYTARABINE; DAUNORUBICIN
US 10,028,912, product and use patent
patent.txt line 10,327- Flags
- product use code U-3149
- Product numbers
- 001
15 Oct 2032 · NDA 209401 · CYTARABINE; DAUNORUBICIN
US 10,028,912, product and use patent
patent.txt line 10,328- Flags
- product use code U-3150
- Product numbers
- 001
15 Oct 2032 · NDA 209401 · CYTARABINE; DAUNORUBICIN
US 10,166,184, product and use patent
patent.txt line 10,330- Flags
- product use code U-3149
- Product numbers
- 001
15 Oct 2032 · NDA 209401 · CYTARABINE; DAUNORUBICIN
US 10,835,492, use patent
patent.txt line 10,332- Flags
- use code U-3150
- Product numbers
- 001
16 Oct 2032 · NDA 050444 · MINOCYCLINE HYDROCHLORIDE
US 11,944,634, product patent
patent.txt line 2,136- Flags
- product
- Product numbers
- 001
16 Oct 2032 · NDA 211635 · DIAZEPAM
US 12,324,852, use patent
patent.txt lines 12,911, 12,919, 12,927- Flags
- use code U-4173
- Product numbers
- 001, 002, 003
16 Oct 2032 · NDA 211651 · TALAZOPARIB TOSYLATE
US 8,012,976, substance and product patent
patent.txt lines 12,934, 12,939, 12,945, 12,950, 12,956, 12,962- Flags
- substance product
- Product numbers
- 001, 002, 003, 004, 005, 006
16 Oct 2032 · NDA 217439 · TALAZOPARIB TOSYLATE
US 8,012,976, substance and product patent
patent.txt lines 19,947, 19,953, 19,959, 19,965, 19,971, 19,977- Flags
- substance product
- Product numbers
- 001, 002, 003, 004, 005, 006
21 Oct 2032 · NDA 219407 · DONIDALORSEN SODIUM
US 9,315,811, use patent
patent.txt line 21,728- Flags
- use code U-3010
- Product numbers
- 001
24 Oct 2032 · NDA 210854 · BALOXAVIR MARBOXIL
US 8,987,441, substance and product patent
patent.txt lines 12,191, 12,202, 12,213- Flags
- substance product
- Product numbers
- 001, 002, 003
24 Oct 2032 · NDA 214410 · BALOXAVIR MARBOXIL
US 8,987,441, substance and product patent
patent.txt lines 15,763, 15,774, 15,785- Flags
- substance product
- Product numbers
- 001, 002, 003
26 Oct 2032 · NDA 214662 · MARALIXIBAT CHLORIDE
US 10,512,657, use patent
patent.txt line 15,921- Flags
- use code U-3850
- Product numbers
- 001
26 Oct 2032 · NDA 214662 · MARALIXIBAT CHLORIDE
US 10,512,657, use patent
patent.txt line 15,935- Flags
- use code U-3973
- Product numbers
- 002
26 Oct 2032 · NDA 214662 · MARALIXIBAT CHLORIDE
US 11,229,661, use patent
patent.txt line 15,924- Flags
- use code U-3850
- Product numbers
- 001
26 Oct 2032 · NDA 214662 · MARALIXIBAT CHLORIDE
US 11,229,661, use patent
patent.txt line 15,936- Flags
- use code U-3973
- Product numbers
- 002
26 Oct 2032 · NDA 214662 · MARALIXIBAT CHLORIDE
US 11,376,251, use patent
patent.txt line 15,927- Flags
- use code U-3290
- Product numbers
- 001
26 Oct 2032 · NDA 214662 · MARALIXIBAT CHLORIDE
US 11,376,251, use patent
patent.txt line 15,928- Flags
- use code U-3974
- Product numbers
- 001
26 Oct 2032 · NDA 214662 · MARALIXIBAT CHLORIDE
US 12,350,267, use patent
patent.txt line 15,937- Flags
- use code U-3973
- Product numbers
- 002
26 Oct 2032 · NDA 216196 · MITAPIVAT SULFATE
US 9,193,701, use patent
patent.txt lines 18,437, 18,446, 18,455- Flags
- use code U-3319
- Product numbers
- 001, 002, 003
26 Oct 2032 · NDA 216196 · MITAPIVAT SULFATE
US 9,193,701, use patent
patent.txt line 18,462- Flags
- use code U-4393
- Product numbers
- 004
26 Oct 2032 · NDA 219485 · MARALIXIBAT CHLORIDE
US 10,512,657, use patent
patent.txt lines 21,747, 21,756, 21,765, 21,774- Flags
- use code U-4186
- Product numbers
- 001, 002, 003, 004
26 Oct 2032 · NDA 219485 · MARALIXIBAT CHLORIDE
US 11,229,661, use patent
patent.txt lines 21,749, 21,758, 21,767, 21,776- Flags
- use code U-4186
- Product numbers
- 001, 002, 003, 004
26 Oct 2032 · NDA 219485 · MARALIXIBAT CHLORIDE
US 11,376,251, use patent
patent.txt lines 21,751, 21,760, 21,769, 21,778- Flags
- use code U-4187
- Product numbers
- 001, 002, 003, 004
26 Oct 2032 · NDA 219485 · MARALIXIBAT CHLORIDE
US 12,350,267, use patent
patent.txt lines 21,755, 21,764, 21,773, 21,782- Flags
- use code U-3973
- Product numbers
- 001, 002, 003, 004
30 Oct 2032 · NDA 212839 · CENOBAMATE
US 7,598,279, substance patent
patent.txt lines 14,438, 14,440, 14,442, 14,444, 14,446, 14,448- Flags
- substance
- Product numbers
- 001, 002, 003, 004, 005, 006
1 Nov 2032 · NDA 205065 · SAPROPTERIN DIHYDROCHLORIDE
US 9,216,178, product patent
patent.txt lines 5,198, 5,200- Flags
- product
- Product numbers
- 001, 002
1 Nov 2032 · NDA 215168 · FLURPIRIDAZ F-18
US 9,687,571, product and use patent
patent.txt line 16,512- Flags
- product use code U-4011
- Product numbers
- 001
3 Nov 2032 · NDA 205004 · BORTEZOMIB
US 8,962,572, product patent
patent.txt line 5,192- Flags
- product
- Product numbers
- 001
6 Nov 2032 · NDA 204308 · ENALAPRIL MALEATE
US 8,568,747, product patent
patent.txt line 4,461- Flags
- product
- Product numbers
- 001
6 Nov 2032 · NDA 204308 · ENALAPRIL MALEATE
US 8,778,366, use patent
patent.txt line 4,462- Flags
- use code U-1723
- Product numbers
- 001
6 Nov 2032 · NDA 204308 · ENALAPRIL MALEATE
US 8,778,366, use patent
patent.txt line 4,463- Flags
- use code U-185
- Product numbers
- 001
6 Nov 2032 · NDA 204308 · ENALAPRIL MALEATE
US 8,778,366, use patent
patent.txt line 4,464- Flags
- use code U-1892
- Product numbers
- 001
6 Nov 2032 · NDA 204308 · ENALAPRIL MALEATE
US 8,778,366, use patent
patent.txt line 4,465- Flags
- use code U-3
- Product numbers
- 001
6 Nov 2032 · NDA 204308 · ENALAPRIL MALEATE
US 8,778,366, use patent
patent.txt line 4,466- Flags
- use code U-71
- Product numbers
- 001
6 Nov 2032 · NDA 204308 · ENALAPRIL MALEATE
US 9,855,214, product patent
patent.txt line 4,467- Flags
- product
- Product numbers
- 001
6 Nov 2032 · NDA 204308 · ENALAPRIL MALEATE
US 9,968,553, use patent
patent.txt line 4,468- Flags
- use code U-1723
- Product numbers
- 001
6 Nov 2032 · NDA 204308 · ENALAPRIL MALEATE
US 9,968,553, use patent
patent.txt line 4,469- Flags
- use code U-185
- Product numbers
- 001
6 Nov 2032 · NDA 204308 · ENALAPRIL MALEATE
US 9,968,553, use patent
patent.txt line 4,470- Flags
- use code U-1892
- Product numbers
- 001
6 Nov 2032 · NDA 204308 · ENALAPRIL MALEATE
US 9,968,553, use patent
patent.txt line 4,471- Flags
- use code U-3
- Product numbers
- 001
6 Nov 2032 · NDA 204308 · ENALAPRIL MALEATE
US 9,968,553, use patent
patent.txt line 4,472- Flags
- use code U-71
- Product numbers
- 001
7 Nov 2032 · NDA 201848 · MELPHALAN HYDROCHLORIDE
US 10,098,997, product patent
patent.txt line 2,584- Flags
- product
- Product numbers
- 001
7 Nov 2032 · NDA 201848 · MELPHALAN HYDROCHLORIDE
US 10,369,264, product patent
patent.txt line 2,586- Flags
- product
- Product numbers
- 001
7 Nov 2032 · NDA 201848 · MELPHALAN HYDROCHLORIDE
US 10,569,004, use patent
patent.txt line 2,587- Flags
- use code U-3680
- Product numbers
- 001
7 Nov 2032 · NDA 201848 · MELPHALAN HYDROCHLORIDE
US 10,569,004, use patent
patent.txt line 2,588- Flags
- use code U-3683
- Product numbers
- 001
7 Nov 2032 · NDA 201848 · MELPHALAN HYDROCHLORIDE
US 11,241,522, product patent
patent.txt line 2,590- Flags
- product
- Product numbers
- 001
7 Nov 2032 · NDA 201848 · MELPHALAN HYDROCHLORIDE
US 11,633,528, use patent
patent.txt line 2,591- Flags
- use code U-3675
- Product numbers
- 001
7 Nov 2032 · NDA 207533 · ARIPIPRAZOLE LAUROXIL
US 9,034,867, product and use patent
patent.txt lines 7,288, 7,305, 7,323, 7,341- Flags
- product use code U-543
- Product numbers
- 001, 002, 003, 004
12 Nov 2032 · NDA 214916 · DIFELIKEFALIN ACETATE
US 7,402,564, substance and product and use patent
patent.txt line 16,328- Flags
- substance product use code U-3204
- Product numbers
- 001
15 Nov 2032 · NDA 202107 · MIFEPRISTONE
US 10,842,801, use patent
patent.txt line 2,768- Flags
- use code U-1643
- Product numbers
- 001
16 Nov 2032 · NDA 208341 · SOFOSBUVIR; VELPATASVIR
US 8,575,135, substance and product and use patent
patent.txt lines 8,492, 8,522- Flags
- substance product use code U-1470
- Product numbers
- 001, 002
16 Nov 2032 · NDA 208341 · SOFOSBUVIR; VELPATASVIR
US 8,921,341, substance and product and use patent
patent.txt lines 8,504, 8,534- Flags
- substance product use code U-1470
- Product numbers
- 001, 002
16 Nov 2032 · NDA 208341 · SOFOSBUVIR; VELPATASVIR
US 8,940,718, substance and product and use patent
patent.txt lines 8,506, 8,536- Flags
- substance product use code U-1470
- Product numbers
- 001, 002
16 Nov 2032 · NDA 209184 · LEVODOPA
US 8,545,878, product patent
patent.txt line 9,807- Flags
- product
- Product numbers
- 001
16 Nov 2032 · NDA 209184 · LEVODOPA
US 8,685,442, product patent
patent.txt line 9,808- Flags
- product
- Product numbers
- 001
16 Nov 2032 · NDA 209184 · LEVODOPA
US 8,945,612, product patent
patent.txt line 9,809- Flags
- product
- Product numbers
- 001
16 Nov 2032 · NDA 209184 · LEVODOPA
US 9,393,210, product patent
patent.txt line 9,810- Flags
- product
- Product numbers
- 001
16 Nov 2032 · NDA 209195 · SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US 8,575,135, substance and product and use patent
patent.txt line 9,826- Flags
- substance product use code U-2039
- Product numbers
- 001
16 Nov 2032 · NDA 209195 · SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US 8,575,135, substance and product and use patent
patent.txt line 9,827- Flags
- substance product use code U-2040
- Product numbers
- 001
16 Nov 2032 · NDA 209195 · SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US 8,921,341, substance and product and use patent
patent.txt line 9,844- Flags
- substance product use code U-2039
- Product numbers
- 001
16 Nov 2032 · NDA 209195 · SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US 8,921,341, substance and product and use patent
patent.txt line 9,845- Flags
- substance product use code U-2040
- Product numbers
- 001
16 Nov 2032 · NDA 209195 · SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US 8,940,718, substance and product and use patent
patent.txt line 9,847- Flags
- substance product use code U-2039
- Product numbers
- 001
16 Nov 2032 · NDA 209195 · SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US 8,940,718, substance and product and use patent
patent.txt line 9,848- Flags
- substance product use code U-2040
- Product numbers
- 001
16 Nov 2032 · NDA 209195 · SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US 9,868,745, substance and product patent
patent.txt line 9,858- Flags
- substance product
- Product numbers
- 001
16 Nov 2032 · NDA 214187 · SOFOSBUVIR; VELPATASVIR
US 8,575,135, substance and product and use patent
patent.txt lines 15,585, 15,613- Flags
- substance product use code U-1470
- Product numbers
- 001, 002
16 Nov 2032 · NDA 214187 · SOFOSBUVIR; VELPATASVIR
US 8,921,341, substance and product and use patent
patent.txt lines 15,597, 15,625- Flags
- substance product use code U-1470
- Product numbers
- 001, 002
16 Nov 2032 · NDA 214187 · SOFOSBUVIR; VELPATASVIR
US 8,940,718, substance and product and use patent
patent.txt lines 15,599, 15,627- Flags
- substance product use code U-1470
- Product numbers
- 001, 002
16 Nov 2032 · NDA 215515 · VUTRISIRAN SODIUM
US 10,570,391, substance and product and use patent
patent.txt line 17,415- Flags
- substance product use code U-3396
- Product numbers
- 001
16 Nov 2032 · NDA 215515 · VUTRISIRAN SODIUM
US 9,399,775, substance and product and use patent
patent.txt line 17,425- Flags
- substance product use code U-3396
- Product numbers
- 001
18 Nov 2032 · NDA 214787 · REMDESIVIR
US 10,065,958, substance patent
patent.txt lines 16,122, 16,161- Flags
- substance
- Product numbers
- 001, 002
19 Nov 2032 · NDA 203168 · BROMFENAC SODIUM
US 10,085,958, product patent
patent.txt line 3,649- Flags
- product
- Product numbers
- 001
19 Nov 2032 · NDA 213591 · CAPMATINIB HYDROCHLORIDE
US 7,767,675, substance and product patent
patent.txt lines 15,141, 15,148- Flags
- substance product
- Product numbers
- 001, 002
19 Nov 2032 · NDA 213876 · HYDROCORTISONE
US 9,717,740, use patent
patent.txt lines 15,288, 15,291, 15,294, 15,297- Flags
- use code U-3075
- Product numbers
- 001, 002, 003, 004
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,258,630, use patent
patent.txt lines 8,794, 8,826- Flags
- use code U-2316
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,258,630, use patent
patent.txt lines 8,795, 8,827- Flags
- use code U-2317
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,398,708, use patent
patent.txt lines 8,796, 8,828- Flags
- use code U-2317
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,398,708, use patent
patent.txt lines 8,797, 8,829- Flags
- use code U-2614
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,471,072, use patent
patent.txt lines 8,798, 8,830- Flags
- use code U-2316
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,471,072, use patent
patent.txt lines 8,799, 8,831- Flags
- use code U-2317
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,537,581, product and use patent
patent.txt lines 8,800, 8,832- Flags
- product use code U-2316
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,537,581, product and use patent
patent.txt lines 8,801, 8,833- Flags
- product use code U-2317
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,568,891, use patent
patent.txt lines 8,802, 8,834- Flags
- use code U-2316
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,568,891, use patent
patent.txt lines 8,803, 8,835- Flags
- use code U-2317
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,668,082, use patent
patent.txt lines 8,804, 8,836- Flags
- use code U-2316
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,668,082, use patent
patent.txt lines 8,805, 8,837- Flags
- use code U-2317
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,806,697, product patent
patent.txt lines 8,806, 8,838- Flags
- product
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,835,487, use patent
patent.txt lines 8,807, 8,839- Flags
- use code U-2316
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,835,487, use patent
patent.txt lines 8,808, 8,840- Flags
- use code U-2317
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,888,516, use patent
patent.txt lines 8,809, 8,841- Flags
- use code U-2316
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 10,888,516, use patent
patent.txt lines 8,810, 8,842- Flags
- use code U-2317
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 11,065,197, product patent
patent.txt lines 8,811, 8,843- Flags
- product
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 11,116,717, product patent
patent.txt lines 8,812, 8,844- Flags
- product
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 11,123,283, product patent
patent.txt lines 8,813, 8,845- Flags
- product
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 11,241,445, use patent
patent.txt lines 8,814, 8,846- Flags
- use code U-2316
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 11,241,445, use patent
patent.txt lines 8,815, 8,847- Flags
- use code U-2317
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 11,246,875, use patent
patent.txt lines 8,816, 8,848- Flags
- use code U-2316
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 11,246,875, use patent
patent.txt lines 8,817, 8,849- Flags
- use code U-2317
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 11,304,959, product patent
patent.txt lines 8,820, 8,852- Flags
- product
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 11,351,182, use patent
patent.txt lines 8,821, 8,853- Flags
- use code U-2316
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 11,351,182, use patent
patent.txt lines 8,822, 8,854- Flags
- use code U-2317
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 11,497,709, use patent
patent.txt line 8,855- Flags
- use code U-2316
- Product numbers
- 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 11,497,709, use patent
patent.txt line 8,856- Flags
- use code U-2317
- Product numbers
- 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 9,180,091, product and use patent
patent.txt lines 8,823, 8,857- Flags
- product use code U-2316
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 9,180,091, product and use patent
patent.txt lines 8,824, 8,858- Flags
- product use code U-2317
- Product numbers
- 001, 002
21 Nov 2032 · NDA 208564 · ESTRADIOL
US 9,289,382, product patent
patent.txt lines 8,825, 8,859- Flags
- product
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 10,052,386, product patent
patent.txt lines 11,106, 11,128- Flags
- product
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 10,206,932, use patent
patent.txt lines 11,107, 11,129- Flags
- use code U-2439
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 10,639,375, product patent
patent.txt line 11,108- Flags
- product
- Product numbers
- 001
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 10,675,288, use patent
patent.txt lines 11,109, 11,130- Flags
- use code U-2439
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 10,806,740, product and use patent
patent.txt line 11,110- Flags
- product use code U-2439
- Product numbers
- 001
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 11,033,626, product and use patent
patent.txt lines 11,111, 11,131- Flags
- product use code U-2439
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 11,103,513, use patent
patent.txt line 11,112- Flags
- use code U-2439
- Product numbers
- 001
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 11,103,516, product patent
patent.txt line 11,113- Flags
- product
- Product numbers
- 001
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 11,110,099, product patent
patent.txt line 11,114- Flags
- product
- Product numbers
- 001
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 11,166,963, product patent
patent.txt line 11,132- Flags
- product
- Product numbers
- 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 11,529,360, product patent
patent.txt line 11,115- Flags
- product
- Product numbers
- 001
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 11,793,819, use patent
patent.txt lines 11,116, 11,133- Flags
- use code U-2439
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 11,865,179, substance and product patent
patent.txt lines 11,117, 11,134- Flags
- substance product
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 8,633,178, product patent
patent.txt lines 11,118, 11,135- Flags
- product
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 8,846,648, use patent
patent.txt lines 11,119, 11,136- Flags
- use code U-2439
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 8,846,649, product and use patent
patent.txt lines 11,120, 11,137- Flags
- product use code U-2439
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 8,933,059, product and use patent
patent.txt line 11,138- Flags
- product use code U-2439
- Product numbers
- 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 8,987,237, product patent
patent.txt lines 11,121, 11,139- Flags
- product
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 8,993,548, product patent
patent.txt lines 11,122, 11,140- Flags
- product
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 8,993,549, product patent
patent.txt lines 11,123, 11,141- Flags
- product
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 9,006,222, product and use patent
patent.txt line 11,124- Flags
- product use code U-2439
- Product numbers
- 001
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 9,114,145, use patent
patent.txt lines 11,125, 11,142- Flags
- use code U-2439
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 9,114,146, product and use patent
patent.txt lines 11,126, 11,143- Flags
- product use code U-2439
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210132 · ESTRADIOL; PROGESTERONE
US 9,301,920, product and use patent
patent.txt lines 11,127, 11,144- Flags
- product use code U-2439
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210496 · ENCORAFENIB
US 10,258,622, use patent
patent.txt line 11,519- Flags
- use code U-2802
- Product numbers
- 002
21 Nov 2032 · NDA 210496 · ENCORAFENIB
US 10,258,622, use patent
patent.txt line 11,520- Flags
- use code U-4051
- Product numbers
- 002
21 Nov 2032 · NDA 210496 · ENCORAFENIB
US 10,258,622, use patent
patent.txt line 11,521- Flags
- use code U-4439
- Product numbers
- 002
21 Nov 2032 · NDA 210496 · ENCORAFENIB
US 9,387,208, product patent
patent.txt lines 11,507, 11,535- Flags
- product
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210496 · ENCORAFENIB
US 9,763,941, use patent
patent.txt lines 11,510, 11,541- Flags
- use code U-2335
- Product numbers
- 001, 002
21 Nov 2032 · NDA 210656 · GLASDEGIB MALEATE
US 8,148,401, substance and product patent
patent.txt lines 12,086, 12,091- Flags
- substance product
- Product numbers
- 001, 002
26 Nov 2032 · NDA 214377 · VERICIGUAT
US 9,604,948, substance and product and use patent
patent.txt lines 15,740, 15,746, 15,752- Flags
- substance product use code U-3062
- Product numbers
- 001, 002, 003
27 Nov 2032 · NDA 214510 · BENZOYL PEROXIDE
US 9,687,465, product and use patent
patent.txt line 15,827- Flags
- product use code U-3356
- Product numbers
- 001
28 Nov 2032 · NDA 211349 · GILTERITINIB FUMARATE
US 8,969,336, substance and product patent
patent.txt line 12,713- Flags
- substance product
- Product numbers
- 001
30 Nov 2032 · NDA 207924 · BARICITINIB
US 11,045,474, use patent
patent.txt lines 7,474, 7,480, 7,486- Flags
- use code U-3372
- Product numbers
- 001, 002, 003
30 Nov 2032 · NDA 207924 · BARICITINIB
US 9,089,574, use patent
patent.txt lines 7,478, 7,484, 7,489- Flags
- use code U-3372
- Product numbers
- 001, 002, 003
6 Dec 2032 · NDA 207533 · ARIPIPRAZOLE LAUROXIL
US 12,629,366, product and use patent
patent.txt lines 7,284, 7,301, 7,319, 7,337- Flags
- product use code U-764
- Product numbers
- 001, 002, 003, 004
12 Dec 2032 · NDA 212489 · OPICAPONE
US 9,630,955, substance and product and use patent
patent.txt lines 14,094, 14,105- Flags
- substance product use code U-3869
- Product numbers
- 001, 002
21 Dec 2032 · NDA 206110 · CASPOFUNGIN ACETATE
US 9,636,407, product patent
patent.txt lines 6,288–6,289- Flags
- product
- Product numbers
- 001, 002
21 Dec 2032 · NDA 207932 · BUPRENORPHINE HYDROCHLORIDE
US 9,901,539, use patent
patent.txt lines 7,657, 7,660, 7,663, 7,666, 7,669, 7,672, 7,675- Flags
- use code U-1556
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
25 Dec 2032 · NDA 213436 · DIHYDROERGOTAMINE MESYLATE
US 10,507,295, product patent
patent.txt line 15,013- Flags
- product
- Product numbers
- 001
28 Dec 2032 · NDA 213137 · VOXELOTOR
US 10,017,491, product patent
patent.txt lines 14,666, 14,679- Flags
- product
- Product numbers
- 001, 002
28 Dec 2032 · NDA 213137 · VOXELOTOR
US 10,034,879, substance and product patent
patent.txt lines 14,667, 14,680- Flags
- substance product
- Product numbers
- 001, 002
28 Dec 2032 · NDA 213137 · VOXELOTOR
US 10,806,733, substance patent
patent.txt lines 14,670, 14,683- Flags
- substance
- Product numbers
- 001, 002
28 Dec 2032 · NDA 216157 · VOXELOTOR
US 10,017,491, product patent
patent.txt line 18,365- Flags
- product
- Product numbers
- 001
28 Dec 2032 · NDA 216157 · VOXELOTOR
US 10,034,879, substance and product patent
patent.txt line 18,366- Flags
- substance product
- Product numbers
- 001
28 Dec 2032 · NDA 216157 · VOXELOTOR
US 10,806,733, substance patent
patent.txt line 18,368- Flags
- substance
- Product numbers
- 001
30 Dec 2032 · NDA 201848 · MELPHALAN HYDROCHLORIDE
US 11,083,831, product patent
patent.txt line 2,589- Flags
- product
- Product numbers
- 001
30 Dec 2032 · NDA 201848 · MELPHALAN HYDROCHLORIDE
US 11,833,286, product patent
patent.txt line 2,592- Flags
- product
- Product numbers
- 001
Pediatric exclusivity, as listed (23)
4 Jul 2032 · NDA 021038 · DEXMEDETOMIDINE HYDROCHLORIDE
US 8,242,158 with pediatric exclusivity, as listed
patent.txt lines 408, 421, 433- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 002, 003, 004
4 Jul 2032 · NDA 021038 · DEXMEDETOMIDINE HYDROCHLORIDE
US 8,338,470 with pediatric exclusivity, as listed
patent.txt lines 410, 423, 435- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 002, 003, 004
4 Jul 2032 · NDA 021038 · DEXMEDETOMIDINE HYDROCHLORIDE
US 8,455,527 with pediatric exclusivity, as listed
patent.txt lines 412, 425, 437- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 002, 003, 004
4 Jul 2032 · NDA 021038 · DEXMEDETOMIDINE HYDROCHLORIDE
US 8,648,106 with pediatric exclusivity, as listed
patent.txt lines 414, 427, 439- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 002, 003, 004
4 Jul 2032 · NDA 021038 · DEXMEDETOMIDINE HYDROCHLORIDE
US 9,320,712 with pediatric exclusivity, as listed
patent.txt lines 416, 429, 441- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 002, 003, 004
4 Jul 2032 · NDA 021038 · DEXMEDETOMIDINE HYDROCHLORIDE
US 9,616,049 with pediatric exclusivity, as listed
patent.txt lines 418, 431, 443- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 002, 003, 004
19 Jul 2032 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR
US 8,648,037 with pediatric exclusivity, as listed
patent.txt line 10,310- Flags
- substance product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
19 Jul 2032 · NDA 215110 · GLECAPREVIR; PIBRENTASVIR
US 8,648,037 with pediatric exclusivity, as listed
patent.txt line 16,485- Flags
- substance product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
27 Jul 2032 · NDA 217026 · TROFINETIDE
US 9,212,204 with pediatric exclusivity, as listed
patent.txt line 19,255- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
27 Jul 2032 · NDA 219884 · TROFINETIDE
US 9,212,204 with pediatric exclusivity, as listed
patent.txt lines 22,043, 22,051, 22,059- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003
28 Jul 2032 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
US 8,580,304 with pediatric exclusivity, as listed
patent.txt lines 4,275, 4,295, 4,315- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003
28 Jul 2032 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
US 9,155,706 with pediatric exclusivity, as listed
patent.txt lines 4,285, 4,305, 4,325- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003
28 Jul 2032 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
US 9,271,941 with pediatric exclusivity, as listed
patent.txt lines 4,287, 4,307, 4,327- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003
28 Jul 2032 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
US 9,399,021 with pediatric exclusivity, as listed
patent.txt lines 4,289, 4,309, 4,329- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003
4 Sep 2032 · NDA 021660 · PACLITAXEL
US 9,393,318 with pediatric exclusivity, as listed
patent.txt line 667- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
4 Sep 2032 · NDA 021660 · PACLITAXEL
US 9,597,409 with pediatric exclusivity, as listed
patent.txt line 671- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
7 Sep 2032 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 10,596,120 with pediatric exclusivity, as listed
patent.txt lines 9,038, 9,070, 9,102, 9,132- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
21 Sep 2032 · NDA 204447 · VORTIOXETINE HYDROBROMIDE
US 9,278,096 with pediatric exclusivity, as listed
patent.txt lines 4,712, 4,732, 4,752, 4,772- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003, 004
30 Sep 2032 · NDA 022527 · FINGOLIMOD HYDROCHLORIDE
US 9,592,208 with pediatric exclusivity, as listed
patent.txt line 2,050- Flags
- product pediatric, as listed by FDA (from the base row)
- Product numbers
- 002
7 Oct 2032 · NDA 022068 · NILOTINIB HYDROCHLORIDE
US 9,061,029 with pediatric exclusivity, as listed
patent.txt lines 1,005, 1,019, 1,033- Flags
- substance pediatric, as listed by FDA (from the base row)
- Product numbers
- 001, 002, 003
10 Nov 2032 · NDA 022088 · TEMSIROLIMUS
US 8,791,097 with pediatric exclusivity, as listed
patent.txt line 1,048- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
18 Nov 2032 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR
US 8,937,150 with pediatric exclusivity, as listed
patent.txt line 10,314- Flags
- substance product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
18 Nov 2032 · NDA 215110 · GLECAPREVIR; PIBRENTASVIR
US 8,937,150 with pediatric exclusivity, as listed
patent.txt line 16,488- Flags
- substance product pediatric, as listed by FDA (from the base row)
- Product numbers
- 001
Non-patent exclusivity (20)
3 Jul 2032 · NDA 219301 · SEBETRALSTAT
ODE-534 exclusivity
exclusivity.txt line 2,268- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
24 Jul 2032 · NDA 210238 · AVATROMBOPAG MALEATE
ODE-548 exclusivity
exclusivity.txt line 858- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
24 Jul 2032 · NDA 219696 · AVATROMBOPAG MALEATE
ODE-548 exclusivity
exclusivity.txt line 2,319- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
28 Jul 2032 · NDA 215014 · PEGCETACOPLAN
ODE-533 exclusivity
exclusivity.txt line 1,462- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
28 Jul 2032 · NDA 215014 · PEGCETACOPLAN
ODE-539 exclusivity
exclusivity.txt line 1,463- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
28 Jul 2032 · NDA 219666 · SEPIAPTERIN
ODE-542 exclusivity
exclusivity.txt lines 2,312, 2,314- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
30 Jul 2032 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
ODE-540 exclusivity
exclusivity.txt lines 863, 867- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
6 Aug 2032 · NDA 219876 · DORDAVIPRONE HYDROCHLORIDE
ODE-547 exclusivity
exclusivity.txt line 2,339- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
21 Aug 2032 · NDA 219407 · DONIDALORSEN SODIUM
ODE-550 exclusivity
exclusivity.txt line 2,282- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
29 Aug 2032 · NDA 219685 · RILZABRUTINIB
ODE-552 exclusivity
exclusivity.txt line 2,317- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
19 Sep 2032 · NDA 215244 · ELAMIPRETIDE HYDROCHLORIDE
ODE-551 exclusivity
exclusivity.txt line 1,501- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
25 Sep 2032 · NDA 219070 · PALTUSOTINE HYDROCHLORIDE
ODE-537 exclusivity
exclusivity.txt lines 2,238, 2,240- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
26 Sep 2032 · NDA 217628 · CLOTRIMAZOLE
ODE-549 exclusivity
exclusivity.txt line 1,897- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
7 Oct 2032 · NDA 218764 · NERANDOMILAST
ODE-546 exclusivity
exclusivity.txt lines 2,187, 2,190- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
23 Oct 2032 · NDA 214988 · DEHYDRATED ALCOHOL
ODE-521 exclusivity
exclusivity.txt line 1,445- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
18 Nov 2032 · NDA 219947 · PLOZASIRAN SODIUM
ODE-541 exclusivity
exclusivity.txt line 2,364- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001
19 Nov 2032 · NDA 213756 · SELUMETINIB SULFATE
ODE-545 exclusivity
exclusivity.txt lines 1,259, 1,263- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
19 Nov 2032 · NDA 219943 · SELUMETINIB SULFATE
ODE* exclusivity
exclusivity.txt lines 2,359, 2,363- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
3 Dec 2032 · NDA 216059 · PIRTOBRUTINIB
ODE-518 exclusivity
exclusivity.txt lines 1,717, 1,722- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 001, 002
23 Dec 2032 · NDA 216196 · MITAPIVAT SULFATE
ODE-522 exclusivity
exclusivity.txt line 1,744- Definition
- Orphan drug exclusivity (to be checked against FDA's list)
- Product numbers
- 004